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Context: Given the public health significance of late-
life depression and anxiety, and the limited capacity of
treatment, there is an urgent need to develop effective
strategies to prevent these disorders.
Objective: To determine the effectiveness of an indi-
cated stepped-care prevention program for depression and
anxiety disorders in the elderly.
Design: Randomized controlled trial with recruitment
between October 1, 2004, and October 1, 2005.
Setting: Thirty-three primary care practices in the north-
western part of the Netherlands.
Participants: A total of 170 consenting individuals, 75
years and older, with subthreshold symptom levels of de-
pression or anxiety who did not meet the full diagnostic
criteria for the disorders.
Intervention: Participants were randomly assigned to
a preventive stepped-care program (n=86) or to usual
care (n=84). Stepped-care participants sequentially re-
ceived a watchful waiting approach, cognitive behavior
therapy–based bibliotherapy, cognitive behavior therapy–
based problem-solving treatment, and referral to pri-
mary care for medication, if required.
Main Outcome Measures: The cumulative inci-
dence of DSM-IV major depressive disorder or anxiety
disorder after 12 months as measured using the Mini In-
ternational Neuropsychiatric Interview.
Results: The intervention halved the 12-month inci-
dence of depressive and anxiety disorders, from 0.24 (20
of 84) in the usual care group to 0.12 (10 of 86) in the
stepped-care group (relative risk, 0.49; 95% confidence
interval, 0.24 to 0.98).
Conclusions: Indicated stepped-care prevention of de-
pression and anxiety in elderly individuals is effective in
reducing the risk of onset of these disorders and is valu-
able as seen from the public health perspective.
Tr ial Registrat ion : i s r c tn .o rg Ident i f i e r :
ISRCTN26474556.
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D EPRESSION AND ANXIETYare common causes of re-duced quality of life andimpaired functioning inlate life.1-3 Both disor-
ders are associated with excess rates of
mortality, and have considerable eco-
nomic ramifications.4-7 In this study, we
focus on the prevention of depression and
anxiety disorders because in late life these
disorders have a high prevalence, co-
occur frequently, and have a significant
effect on well-being and functioning.4,8-14
Although important advances have been
made in the treatment of anxiety and de-
pression in elderly patients,15 there is still
cause for concern. Even in more affluent
countries, no health service could possi-
bly provide adequate treatment for all, and
even if such a scenario would be conceiv-
able, formidable obstacles in case recog-
nition, diagnosis, and provision of treat-
ment would limit the effectiveness of the
interventions at the population level.16-18
A final concern is that current treatments
are not as effective as we would like them
to be.19,20 Therefore, although treatment
has improved, there is a dire need for al-
ternative strategies, such as effective pre-
vention programs, to alleviate the bur-
den of disease associated with late-life
anxiety and depression.
Mrazek and Haggerty21 suggest 3 types
of interventions to prevent mental disor-
ders: first, “universal preventive interven-
tions” targeted to the general population
(eg, mass media campaigns); second, “se-
lective preventive interventions” tar-
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geted to population segments with increased risk of de-
veloping a mental disorder because they have been
exposed to risk factors (eg, support groups for widows);
and finally, “indicated preventive interventions” tar-
geted to people with some symptoms that possibly fore-
shadow the onset of a mental disorder but who do not
meet the DSM-IV diagnostic criteria. Indicated preven-
tion aims to reduce the occurrence of new cases or to de-
lay the onset of the disorder. In addition, indicated pre-
vention may reduce symptom severity and the time spent
in the subthreshold condition. Of the 3 types of preven-
tive interventions, indicated prevention most closely re-
sembles conventional treatment and has the best chance
of detecting groups of individuals with subthreshold dis-
orders, whose condition harbors a high risk of develop-
ing major anxiety or depression disorder.22-27 Indicated
prevention studies in subclinically depressed popula-
tions have shown a reduction in the incidence of depres-
sion by 25%.28
Taking into account the seriousness of depression and
anxiety in late life and the possibilities of a preventive ap-
proach, the next step was to conduct an evaluation of an
indicated prevention program designed to reduce the in-
cidenceof anxietyanddepressivedisorders inelderlypeople.
The intervention applied in the present study was a stepped-
care program.29,30 The aim of stepped-care models is to maxi-
mize the effectiveness of an intervention while making the
best use of available resources. Although stepped care seems
to be a logical approach from clinical and economic per-
spectives, few studies have investigated the effects of
stepped-care programs, none of which focused on preven-
tive interventions. We hypothesize that a stepped-care pro-
gram designed to reduce the incidence of major depres-
sive and anxiety disorders, offered to elderly people with
subthreshold depressive or anxiety symptoms, would be
more effective than the usual care provided.
METHODS
DESIGN
We conducted a pragmatic randomized clinical trial in 2 par-
allel groups. The intervention was intended to be flexible, to
be closely linked with real-life situations, and to easily fit in
with routine clinical care. Participants were allowed to accept
or reject parts of the treatment. Randomization took place af-
ter the baseline measurements, and participants were random-
ized with equal probability to either usual care or the preven-
tive intervention in blocks of 4 by an independent statistician
using random-number tables. The main clinical outcome was
the cumulative 12-month incidence of anxiety (panic disor-
der, agoraphobia, social phobia, and generalized anxiety) and
depressive disorder meeting theDSM-IV diagnostic criteria and
measured using the Mini International Neuropsychiatric In-
terview (MINI) at 6 and 12 months. In this project we used Mini
Manager 2.0 (created by Edwin de Beurs, Netherlands Insti-
tute of Forensic Psychiatry and Psychology), a computer-
assisted version of the Dutch MINI (5.0). The interviewers who
measured the primary outcome were kept unaware of the ran-
domization status of the participants. The trial was powered
to detect a difference of 25% in the cumulative incidence rates
of MINI/DSM-IV anxiety and depressive disorders between the
conditions across 1 year. These differences were expected to
be 35% in the usual care group and 10% in the intervention
group on the basis of longitudinal studies.31,32 We calculated
that 65 participants per group would be needed, assuming a
2-sided test at =.05 and a power of (1−)=0.90.
To test the impact of the intervention on Center for Epide-
miologic Studies Depression Scale (CES-D) scores across time
(3, 6, 9, and 12 months), we conducted a generalized estimat-
ing equation analysis for Gaussian-distributed data. The study
protocol was approved by the Medical Ethics Committee of the
VU University Medical Center.
PARTICIPANTS
Eligible individuals for this project were identified from the study
population of a large prevention project, the PIKO project (Pre-
ventive Intervention for Frail Elderly), and were recruited be-
tween October 1, 2004, and October 1, 2005. The PIKO project
was based on the results of a self-rated health inventory com-
pleted by general-practice patients 75 years and older. The PIKO
database provided data for 3 studies.33-35 The health inventory
included several questionnaires on which the recruitment of
participants for the 3 studies was based. For this project, it en-
tailed the self-report CES-D, a screening questionnaire for sub-
threshold depression and anxiety. Individuals in the PIKO da-
tabase with a CES-D score of 16 or greater were approached
regarding participation in the stepped-care prevention project.
People 75 years and older with a relevant score on the CES-D
screening questionnaire who did not meet the DSM-IV criteria
for depressive or anxiety disorder according to the MINI dur-
ing the past 12 months were included in the trial. Anxiety dis-
order entailed the following: panic disorder, agoraphobia, so-
cial phobia, or generalized anxiety disorder. Eligible individuals
gave informed consent before inclusion. Elderly individuals with
serious cognitive decline according to the self-rated IQCODE
(Informant Questionnaire on Cognitive Decline in the El-
derly) were excluded.34
The aforementioned PIKO self-rated health inventory, in-
cluding the CES-D, was sent to 5207 elderly individuals. These
individuals were registered in 33 primary care practices in the
northwestern region of the Netherlands. The total number of
people 75 years and older who consented to being screened was
5207. Of these, 2850 (54.7%) completed the CES-D, resulting
in 886 screen positives with CES-D scores of 16 or greater.36
Subsequently, 325 elderly individuals were randomly ap-
proached for participation in the stepped-care anxiety and de-
pression prevention trial. Reckoning with 50% attrition, we
would still have enough participants per group to detect a dif-
ference of 25% in the cumulative incidence rates of MINI/
DSM-IV anxiety and depressive disorders between the condi-
tions across 1 year. Of the 325 approached elderly individuals,
170 (52.3%) met the inclusion criteria and were randomized.
Of the remaining 155 individuals, 105 (67.7%) did not meet
the inclusion criteria and 50 (32.3%) withdrew their consent
before randomization (Figure).
INTERVENTION
It is consistently described that subclinical manifestations of
depressive and anxiety disorders are the best predictors of the
onset of full-blown disorders.22-24,37 It is also understood that
the subclinical manifestations are amenable, particularly through
preventive cognitive behavior therapy–based bibliotherapy and
problem-solving treatment (PST), as is evidenced by a meta-
analysis of randomized prevention trials.28 Both treatment types
help individuals acknowledge their symptoms and encourage
them to switch to more active self-management strategies. This
makes bibliotherapy and PST promising candidates for pre-
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vention; for this reason, we chose them for steps 2 and 3, re-
spectively.
The stepped-care program consisted of the following 4 steps
lasting 3 months each (Table 1):
Step 1:Watchful waiting.Participants with a minimum CES-D
score of 16 were invited to complete a second CES-D question-
naire after 3 months. These first 3 months constituted a period
of watchful waiting, which is appropriate because it is known that
depressive symptoms disappear spontaneously in many cases.
However, if the second measurement revealed a score at or above
the cutoff point, the participant underwent a diagnostic MINI. If
no depressive or anxiety disorder could be established (ie, a nega-
tive MINI result), then it was concluded that the participant had
only subthreshold levels of depression or anxiety. Participants who
met these criteria were randomized.
The interventions in the following steps were offered to par-
ticipants with continuous depressive and anxiety symptoms
(CES-D score of16) as measured at every start of the follow-
ing 3 months.
Step 2: Cognitive behavior therapy–based bibliotherapy. Par-
ticipants received a telephone call in which the intervention
was explained. After the call, participants were visited by a spe-
cially trained home care nurse who delivered a brochure that
contained information about mild depression and anxiety and
simple advice on how to cope with anxiety and depressive symp-
toms. During a subsequent visit, a self-help course (Coping
With Depression) was offered to participants.38-40 For this
study, the Coping With Depression course was extended to a
Coping With Depression and Anxiety version and was
adapted for individual use by people 75 years and older. The
Coping With Depression and Anxiety course helps people
improve social skills, address depressogenic or anxiogenic
thinking, and increase pleasant activities and relaxation to
cope with problems assumed to be related to one’s depres-
sion or anxiety. Participants worked through the course at
their convenience. The nurse made visits (mean [SD], 3 [1])
or telephone calls (mean [SD], 2 [0.5]) to encourage partici-
pants to continue with the course. After 3 months, an evalu-
ation form was completed by the nurse.
Step 3: Brief cognitive behavior therapy–based PST. In this
step, participants were offered PST, which is a brief cognitive
behavioral intervention that focuses on practical skill build-
ing. It consists of 7 sessions during which the stages of prob-
lem solving are explained and then applied to problems that
are encountered in daily life. The goal of PST is to help
patients regain control of their lives.41,42 Again, participants
first received information about the intervention via tele-
phone. If the participant agreed, a specially trained commu-
nity psychiatric nurse made the first appointment for a visit.
All the nurses were familiar with the PST protocol, were
trained during a 2-day PST workshop, and had to attend
monthly supervision meetings. Treatment integrity in this
phase was monitored through tape recordings of the sessions.
The task of these nurses was to help participants acquire
problem-solving skills. At the end of the intervention, an
evaluation form was completed by the nurse.
Step 4: Referral to primary care. Participants with continu-
ously elevated CES-D scores received written advice to dis-
cuss suitable medications (ie, antidepressant or antianxiety medi-
cations) with their primary care physician.
To summarize, the flow of participants in the intervention
group through the stepped-care program depended on having
their symptoms measured using the CES-D every 3 months for
1 year. Participants who still had elevated symptom levels af-
ter the conclusion of an intervention were offered participa-
tion in the next step. A score below the cutoff point resulted in
a period of watchful waiting until an elevated CES-D score in-
dicated the need for the following step of the intervention. People
who met the MINI diagnostic criteria for the disorders at base-
line or at 6 or 12 months, which was considered the main clini-
cal outcome, were referred to their primary care physician.
USUAL CARE
Participants in the usual care group had unrestricted access to
usual care for their depression or anxiety concerns. Their health
care uptake (including their use of prescription medications)
was recorded.
MEASURES
The MINI was administered by trained interviewers at base-
line and at 6 and 12 months. The MINI43,44 is a brief structured
diagnostic interview developed by psychiatrists and physi-
cians in the United States and Europe for DSM-IV and ICD-10
psychiatric disorders. With an administration time of approxi-
mately 20 minutes, the MINI has become the structured inter-
view of choice for psychiatric evaluation in many clinical trials
and epidemiologic studies.
The CES-D45-48 was used to screen for subthreshold depres-
sion and anxiety at baseline and after 3, 6, 9, and 12 months. It
consists of 20 items and has a total score ranging from 0 to 60.
Minimum scores of 16 indicate clinically significant levels of de-
170 Were randomized
7 Were no-shows
3 Refused
2 Had cognitive 
problems
2 Died
4 Were no-shows
3 Refused
1 Died
13 Dropped out
10 Refused
1 Had cognitive 
problems
2 Died
3 Dropped out
1 Refused
1 Had cognitive 
problems
1 Died
4 Dropped out
3 Refused
1 Died
1 Dropped out
1 Died
86 Participants received 
the intervention and were
analyzed (ITT)
66 Underwent 6-mo follow-up 77 Underwent 6-mo follow-up
62 Underwent 12-mo follow-up 76 Underwent 12-mo follow-up
84 Were analyzed (ITT)86 Were analyzed (ITT)
84 Participants received 
usual care and were
analyzed (ITT)
155 Were excluded
80 Did not meet the 
inclusion criteria
50 Refused to participate
25 Were excluded for
other reasons
5207 Individuals (age ≥ 75 y) were mailed PIKO
health questionnaire (including CES-D)
325 Were randomly assessed for eligibility 
for stepped-care depression and
anxiety prevention study
2850 Replied (and completed CES-D)
886 Had a CES-D score ≥ 16
Figure. Flowchart of participants in the trial. CES-D indicates Center for
Epidemiologic Studies Depression Scale; ITT, intention to treat;
PIKO, Preventive Intervention for Frail Elderly.
(REPRINTED) ARCH GEN PSYCHIATRY/ VOL 66 (NO. 3), MAR 2009 WWW.ARCHGENPSYCHIATRY.COM
299
©2009 American Medical Association. All rights reserved.
 at Vrije Universiteit, on November 23, 2010 www.archgenpsychiatry.comDownloaded from 
pressive symptoms. The CES-D has been found to be a satisfac-
tory instrument with which to screen for anxiety disorders.47
STATISTICAL ANALYSIS
The analyses were performed in agreement with the intention-
to-treat principle, that is, all participants were analyzed in the
group to which they were randomized. The analyses were per-
formed using a software program (Stata version 8.2; Stata-
Corp LP, College Station, Texas), in several steps. First, we pre-
sent descriptive statistics of the baseline characteristics of the
intervention group, the usual care group, and total partici-
pants (Table 2).
Second, the intention-to-treat approach requires that analy-
ses of outcome data are based on all randomized participants,
and, therefore, missing observations need to be replaced by their
most likely values while also taking into account the mecha-
nism that generated the missing values. To that end, predic-
tors of outcome and missingness were identified. Predictors of
outcome help obtain the most precise values of the outcome
variable, and predictors of missingness help correct for the bias
that may be caused by differential loss to follow-up, as far as
differential dropout is related to available predictors. The sta-
tistically significant predictors were duly used in a regression
imputation (as implemented in Stata) to obtain the required
predicted values. By way of sensitivity analysis, we also used 2
other imputation strategies. First, we repeated the main analy-
sis, basing it on multiple imputation. To that purpose, missing
end points were not replaced by a single estimate but by 10 new
estimates. For this we used the Stata hotdeck procedure strati-
fied for baseline CES-D score (dichotomized at 20) and age (di-
chotomized at 81 years) because these variables were predic-
tors of outcome and loss to follow-up, respectively. Compared
with regression imputation, this approach produces more con-
servative outcomes that strengthen the null hypothesis of no
effect. Finally, we applied a worst-case scenario and replaced
missing scores with scores indicating that a depressive or anxi-
ety disorder had occurred. This was the most conservative way
to handle missing end points.
Third, to test the hypothesis that the intervention would be
more successful than usual care in reducing the risk of depres-
sion and anxiety disorders, we performed a logistic regression
analysis of the outcome (1=disordered and 0=disorder free) on
the treatment indicator (0=usual care and 1=intervention) to ob-
tain the odds ratio (OR) that describes the reduction in the risk
of a MINI/DSM-IV depressive or anxiety disorder in the inter-
vention group relative to the control group. The superiority of
the intervention would be supported if the OR fell below 1 (in-
dicating risk reduction) and would be significant at P .05,
2-tailed. This analysis was conducted 3 times for each of the dif-
ferent imputation strategies. To gauge the robustness of the find-
ings, we also performed a Poisson regression analysis to obtain
the person-time–based incidence rate ratio and repeated the test
of the hypothesis under this model specification.
Fourth, following the pertinent CONSORT (Consolidated
Standards of Reporting Trials) guideline, we obtained the num-
ber needed to treat as the inverse of the risk difference. The
risk difference was obtained by regressing the outcome on the
treatment indicator variable in a linear probability model. The
latter was specified as a generalized linear model for a binary
outcome, with identity as the link function.
To test the impact of the intervention on CES-D scores across
time, we evaluated the group  time interactions for each of
the time points (3, 6, 9, and 12 months) on the CES-D scores
under a generalized estimating equation model.
RESULTS
PARTICIPANT FLOW
People with a CES-D score of 16 or greater who did not
meet the diagnostic criteria for MINI/DSM-IV depres-
sive or anxiety disorder were invited to participate in the
stepped-care prevention program (n=325). Of these, 170
met all the inclusion criteria and gave informed con-
sent. They were randomized to the intervention (n=86)
or the usual care (n=84) condition (Figure).
BASELINE CHARACTERISTICS
The participants were mainly women (73.5%) and had a
mean (SD) age of 81.4 (3.7) years (Table 2). About 30% of
the participants were married or living with a partner, and
72.9% had an educational level that was lower than or
equivalent to the completion of high school. Almost 50%
had more than 2 chronic physical diseases (such as ische-
mic heart disease and arthritis). At baseline, the mean (SD)
CES-D score was 21.6 (5.1). There were no significant dif-
ferences in sociodemographic or clinical characteristics be-
tween the intervention and usual care groups.
Regarding previous episodes of anxiety or depressive
disorders, 24 participants (14.1%) reported a disorder that
Table 1. Clinical Pathway of the Stepped-Care Program
Step 1 Step 2 Step 3 Step 4
CES-D score 16 Watchful waiting Bibliotherapy PST Medication
CES-D score 16 Watchful waiting Watchful waiting Watchful waiting Watchful waiting
Abbreviations: CES-D, Center for Epidemiologic Studies Depression Scale; PST, problem-solving treatment.
Table 2. Baseline Characteristics of the Participants
Characteristic
Intervention
Group
(n = 86)
Usual-
Care
Group
(n = 84)
Total
(N = 170)
Female sex, No. (%) 60 (69.8) 65 (77.4) 125 (73.5)
Age, mean (SD), y 81.8 (3.8) 81.1 (3.5) 81.4 (3.7)
Married or living with
partner, No. (%)
26 (30.2) 24 (28.6) 50 (29.4)
Education beyond high
school, No. (%)
24 (27.9) 22 (26.2) 46 (27.1)
Rural residence (10 000
inhabitants), No. (%)
36 (41.9) 39 (46.4) 75 (44.1)
Chronic diseases (2),
No. (%)
36 (41.9) 45 (53.6) 81 (47.7)
CES-D score, mean (SD) 21.2 (5.0) 22.1 (5.2) 21.6 (5.1)
Abbreviation: CES-D, Center for Epidemiologic Studies Depression Scale.
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had remitted more than a year preceding randomiza-
tion. These 24 participants were distributed evenly across
the conditions: 11 in the intervention condition and 13
in the usual care condition.
ANALYSIS OF DROPOUT
Wesystematicallyassessedwhetherdropoutwasassociated
with any characteristics of the participants as measured at
baseline.Wefoundthatdropoutwasnotassociatedwithbase-
line depression score (CES-D), age, sex, educational level,
living inasupportedenvironment, thepresenceofasomatic
illness,orlivingalone.However,dropoutwasassociatedwith
randomizationstatus, inparticularwithbeingaparticipant
in the intervention group (21=9.398, P=.002) (Figure).
OUTCOMES
In the intervention group, 10 of 86 participants (11.6%)
developed a major disorder, which compares favorably with
the control group, in which 20 of 84 participants (23.8%)
developed a major disorder, resulting in a relative risk of
0.49 (95% confidence interval [CI], 0.24 to 0.98). The in-
tervention reduced the odds of developing a depressive or
anxiety disorder by 57.9% (OR, 0.42%; 95% CI, 0.18% to
0.96%), concerning the first-ever onset of these disorders
in most participants. The null hypothesis of no effect had
to be rejected (SE=0.18;z=−2.05;P=.04), thus lending sup-
port to the alternative hypothesis that the intervention is
superior to usual care.
To gauge the robustness of the outcome, we repeated
the first analysis, basing it this time on multiple imputa-
tion. This resulted in an OR of 0.34 (95% CI, 0.20 to 0.61),
which was significant (SE=0.252; t=4.227;P .001), thus
replicating the previous results. And finally, the worst-
case analysis provided an OR of 1.19 (95% CI, 0.63 to 2.23),
no longer significant (SE=0.38; z=−0.53; P=.60).
The first analysis was replicated, using Poisson re-
gression analysis: for this analysis, we obtained the person-
time–based incidence rate ratio of 0.47, again confirm-
ing that the risk of disease onset is more than halved by
the intervention. The incidence rate ratio had a 95% CI
of 0.22 to approximately 1.00 (rounded) and was sig-
nificant (SE=0.181; z=−1.97; P=.049).
We obtained the number needed to treat as the inverse
of the risk difference. The risk difference was 0.12 in favor
of the intervention (95% CI, −0.236 to −0.007; SE=0.058;
t=−2.10;P=.04), which lent support to the alternative hy-
pothesis. Its inverse, the number needed to treat, was
1/0.122=8.2, which indicated that the onset of major de-
pression or anxiety disorder was prevented in 1 of every 8
peoplewhoreceivedtheinterventionrather thanusualcare.
The generalized estimating equation model showed
the following coefficients for the group  time interac-
tions for each of the time points on the CES-D scores:
8.2, 11.1, 12.1, and 12.2, indicative of substantial clini-
cal superiority of the intervention compared with care
as usual. The interaction terms were significant: for 3
months at P=.008 and for all other time points at P .001.
This was replicated under the random-effects model,
which produced nearly identical results.
After 1 year, the intervention group showed 4 depres-
sive disorders, 3 anxiety disorders, and 2 co-occurrences
ofdepressionandanxiety. Intheusual-caregroup,wefound
10 depressive disorders, 5 anxiety disorders, and 5 co-
occurrences. The distribution was compared across the 2
groups and was not significant (22=0.2158; P=.90).
USUAL CARE
During the first year of the study, we found that 23 par-
ticipants in the usual-care group received antidepres-
sant or anxiolytic-sedative medications vs 28 in the in-
tervention group (which was not significant [P=.28]).
Regarding counseling or other types of psychoeduca-
tional or psychosocial interventions, 2 participants in the
usual-care group mentioned that they had read informa-
tion about depression or anxiety.
ACCEPTABILITY
To obtain an impression of the acceptability of the in-
tervention, we investigated “no shows,” “dropouts”
(Figure), and the intervention uptake.
At the start of the study, 7 of the 86 intervention group
participants and 4 of the 84 usual-care group partici-
pants chose not to participate. These 7 intervention and
4 usual-care individuals were referred to as no shows
(Figure). A 2-tailed Fisher exact test suggested the ab-
sence of any significant effect (P=.54). We then inves-
tigated the dropout rate across the conditions in those
who did participate. We had 79 remaining intervention
participants and 80 in the usual-care group. During the
first 6 months, the dropout category showed 13 inter-
vention participants (10 refusals) and 3 usual-care par-
ticipants. The second 6-month period showed 4 and 1
dropouts, respectively. Dropout occurred at a signifi-
cantly higher rate in the intervention group (P=.009,
2-tailed Fisher exact test) (Figure). A certain amount of
dropout was due to mortality. In the intervention group,
Table 3. Uptake of Interventions of the Stepped-Care Program by Quarter
Characteristic
Participants, No. (%)
0-3 mo
(n = 79)
4-6 mo
(n = 66)
7-9 mo
(n = 64)
10-12 mo
(n = 62)
Bibliotherapy 79 (100)
Problem-solving treatment 23 (34.8) 14 (21.9) 6 (9.7)
Referral to primary care physician 12 (18.8) 13 (21.0)
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3 of 79 active participants died, and, in the usual-care
group, 2 of 80 active participants died. Mortality was not
related to either condition (P=.99, 2-tailed Fisher exact
test).
Data on the uptake of the interventions of the stepped-
care prevention program are given in Table 3. No par-
ticipants refused bibliotherapy, 9 refused PST, and none
refused the written advice to discuss suitable medica-
tions with their primary care physician. As Table 3 shows,
the stepped-care strategy was considerably successful. We
will return to the acceptability of the intervention in the
“Comment” section.
COMMENT
MAIN FINDINGS
The aim of this study was to test the hypothesis that an
indicated stepped-care intervention to prevent depres-
sive and anxiety disorders in people 75 years and older
is more effective than usual care alone. These data sug-
gest that the intervention halved the 1-year cumulative
incidence rate of the disorders , and the null hypothesis
of equal effectiveness had to be rejected in favor of the
alternative hypothesis that the intervention is more ef-
fective than usual care in reducing the risk of major de-
pression and anxiety.
STRENGTHS AND LIMITATIONS
This study has several strengths. The screening proce-
dure identified a number of elderly individuals with de-
pressive and anxiety symptoms who are usually not rec-
ognized by their primary care physicians as having
problems. This finding is corroborated by evidence found
by the US Preventive Services Task Force49 in 2002 that
screening improves identification of depressed patients
in primary care settings. Another strong feature of this
study is the fact that it was based on the empirically sup-
ported Improving Mood: Promoting Access to Collabo-
rative Care Treatment (IMPACT) study.30 Similar to the
IMPACT study, the present intervention included infor-
mation and options for engaging in brief psychotherapy
sessions or pharmacotherapy treatments in the context
of a stepped-care program. Unlike the IMPACT study,
the present intervention was directed at elderly people
(75 years) and focused on depressive symptoms as op-
posed to diagnosed major depressive disorder, but then
this program is “indicated prevention” and not treat-
ment. A further strength of this intervention is that it also
addressed anxiety, which is especially relevant in light
of the high comorbidity between mood disorders and anxi-
ety disorders.
A limitation of the study design is that it is impos-
sible to assess the specific contributions of each of the
various elements of the stepped-care program. In the
analysis, the intervention had to be treated as a whole; a
completely different study design would be required to
deconstruct this package into its components. Another
limitation concerns the differential dropout rates, which
are of concern because they may indicate that the inter-
vention requires an extra effort from some participants,
despite the apparent successful uptake of the interven-
tion by others. The differential dropout rates may also
have affected the results of the study. However, to over-
come this problem, we performed intention-to-treat analy-
sis based on 3 different imputation techniques, and in
all instances we obtained nearly identical results, which
underscores the robustness of the findings.
PUBLIC HEALTH SIGNIFICANCE
Existing health care systems have difficulties address-
ing the demand for treatment of the vastly increasing num-
ber of elderly people in the population and can only avert
a fraction of the total disease burden that is attributable
to mental disorders.17,18 In this context, it is important
to prevent the onset of mental disorders. To our knowl-
edge, this study is one of the first that supplies evidence
that such an endeavor is effective: these results show that
the risk of anxiety and depressive disorders can be halved
when targeting a high-risk group of people with sub-
threshold manifestations of the pertinent disorders. To
halve the incidence rate of such crippling conditions is
a feat in itself but, better still, the favorable results were
achieved in a possibly economically affordable stepped-
care program. After all, low-cost interventions were of-
fered first, outcomes were monitored, and only if the in-
terventions failed to maintain anxiety and depressive
symptoms at acceptable levels were more intensive in-
terventions offered. This makes the approach not only
clinically effective but also potentially cost-effective.
Only long-term follow-up assessments will shed light
on whether this intervention prevented or delayed men-
tal illness. However, given the often chronic nature of
anxiety and depressive disorders, the more realistic as-
sumption is that we delayed onset in most participants
rather than offering an enduring prophylaxis.50 Al-
though the latter is preferable, delay of onset is impor-
tant in its own right given the disabling nature of these
disorders. Every year lived without an avoidable depres-
sive or anxiety disorder will result in considerably less
suffering by patients and their families.28
We now need to gain better understanding about some
remaining issues: the long-term effects of the interven-
tion, the identification of target groups that would ben-
efit most from the intervention, and the cost-
effectiveness of the intervention.
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